Vaxtex Cotfab accepts Independent Director resignation

1 min read     Updated on 31 May 2026, 02:50 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Vaxtex Cotfab Limited accepted the resignation of Independent Director Ms. Anjali Gupta effective May 31, 2026, due to personal commitments. The company confirmed no other material reasons for the departure in its regulatory filing.

powered bylight_fuzz_icon
41721609

*this image is generated using AI for illustrative purposes only.

Vaxtex Cotfab Limited has accepted the resignation of Ms. Anjali Gupta as an Independent Director on its board, effective May 31, 2026. The resignation was tendered due to pre-occupation and other personal commitments, as confirmed by the company. This change impacts the board composition of the textile manufacturer, which specializes in suiting and shirting fabrics.

The company disclosed that Ms. Gupta submitted her resignation on May 27, 2026. In a regulatory filing, Vaxtex Cotfab confirmed that there are no other material reasons for her resignation beyond those stated in her resignation letter. The resignation was communicated to the National Stock Exchange of India Limited under Regulation 30 of the SEBI (LODR) 2015 regulations.

The following table outlines the key details regarding the director's resignation:

Details of events Information
Reason for change Resignation due to pre-occupation and other personal commitments
Date of Resignation May 27, 2026
Effective Date May 31, 2026

Ms. Anjali Gupta served as the Company Secretary in her resignation letter, which was addressed to the Board of Directors. She expressed gratitude to the board and management for their support and cooperation during her tenure. The company has processed the resignation and updated its records accordingly.

Historical Stock Returns for Vaxtex Cotfab

1 Day5 Days1 Month6 Months1 Year5 Years
+0.72%-2.80%-8.55%-30.50%+40.40%-51.23%

Who will Vaxtex Cotfab appoint to replace Ms. Gupta, and how will this impact the board's governance structure?

Will the departure of an Independent Director affect the company's strategic decisions in the textile sector over the coming year?

How might the market react to this leadership change given the effective date is set for 2026?

Vaxtex Cotfab FY26 net profit rises to ₹552.55 crore

1 min read     Updated on 26 May 2026, 04:09 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Vaxtex Cotfab Limited reported a net profit of ₹552.55 crore for FY26, up from ₹88.36 crore in the previous year, with total income rising to ₹1,442.54 crore. The Board approved the audited standalone financial results, and the trading window will reopen on May 28, 2026.

powered bylight_fuzz_icon
41294339

*this image is generated using AI for illustrative purposes only.

Vaxtex Cotfab Limited reported a net profit of ₹552.55 crore for the financial year ended March 31, 2026, a sharp increase from ₹88.36 crore in the prior year. The company’s total income for FY26 rose to ₹1,442.54 crore, compared to ₹638.23 crore in FY25. Revenue from operations for the year stood at ₹1,116.64 crore, up from ₹525.33 crore in the previous year.

For the quarter ended March 31, 2026, the company posted a net profit of ₹78.85 crore. Revenue from operations for the quarter was nil, while other income contributed ₹49.81 crore to the total income. The Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, along with the Statement of Assets and Liabilities and Statement of Cash Flow.

The financial results were reviewed by the Audit Committee and approved by the Board. Statutory Auditors of the Company carried out the statutory audit. The results were prepared in accordance with India Accounting Standards (Ind AS) prescribed under Section 133 of The Companies Act, 2013. The company operates in a single primary segment, "Trading in Textiles," and thus consolidated results are not applicable.

Financial Performance

The company’s earnings per share (EPS) for the year ended March 31, 2026, was ₹0.30, compared to ₹0.05 in the previous year. For the quarter ended March 31, 2026, the EPS was ₹0.04. Total expenses for the year increased to ₹936.39 crore from ₹597.07 crore in FY25.

Particulars Year Ended March 31, 2026 (₹ In Lakhs) Year Ended March 31, 2025 (₹ In Lakhs)
Total Income 1,442.54 638.23
Total Expenses 936.39 597.07
Net Profit for the period 552.55 88.36
Basic & Diluted EPS (₹) 0.30 0.05

Assets and Liabilities

As of March 31, 2026, the company’s total assets stood at ₹3,682.29 crore, a decrease from ₹4,847.38 crore in the previous year. Total equity increased to ₹2,244.04 crore from ₹1,834.02 crore. Non-current liabilities decreased to ₹184.95 crore from ₹735.35 crore, while current liabilities reduced to ₹1,253.30 crore from ₹2,278.01 crore.

The trading window for dealing in the company’s securities by all Designated Persons and their immediate relatives will reopen from May 28, 2026. The Independent Auditor's Report issued an unmodified opinion on the annual audited standalone financial results.

Historical Stock Returns for Vaxtex Cotfab

1 Day5 Days1 Month6 Months1 Year5 Years
+0.72%-2.80%-8.55%-30.50%+40.40%-51.23%

How will the company sustain its profitability given that Q4 revenue from operations was nil?

What strategic initiatives will be implemented to reduce the significant gap between total income and operating revenue?

Will the company diversify its business model beyond the single 'Trading in Textiles' segment to mitigate risks?

1 Year Returns:+40.40%